Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy ...

Though largely operating in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is set ...

CEO Brian Culley highlighted the progress of OpRegen, noting its differentiation from current anti-complement therapies for dry AMD. He emphasized, “OpRegen has shown evidence of both anatomical and ...

In a new weekly update for pv magazine, OPIS, a Dow Jones company, provides a quick look at the main price trends in the global PV industry. FOB China cell prices declined this week amid weaker market ...

Rusty Konkol wanted to hug everyone he saw during his tour of Iovance Biotherapeutics’ Navy Yard manufacturing facility. The 71-year-old grandfather with metastatic melanoma had flown in from ...

HEFEI, ANHUI, CHINA, January 19, 2026 /EINPresswire.com/ — The global photovoltaic (PV) industry is entering a phase defined less by headline capacity additions and ...

“Bringing solar cell production to our facility underscores our commitment to US manufacturing, job creation, and a transparent, ethical supply chain.” Mission Solar completed a 200,000 square-foot ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

The upcoming Solar Manufacturing USA 2026 conference in Austin will focus on real U.S. solar manufacturing progress, shifting ...

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...